3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
6
Prostatic Neoplasms
3
Oropharyngeal Neoplasms
3
Uterine Cervical Neoplasms
2
Laryngeal Neoplasms
2
Astrocytoma
2
Vaginal Neoplasms
1
Urothelial Carcinoma of the Bladder
1
Urinary Bladder Neoplasms
1
Tongue Neoplasms
1
Sarcoma
1
Salivary Gland Neoplasms
1
Oligodendroglioma
1
Nasopharyngeal Carcinoma
1
Mouth Neoplasms
1
Mesothelioma, Malignant
1
Mesothelioma
1
Lymphoma, Follicular
1
Lung Neoplasms
1
Locally Advanced Cervical Adenocarcinoma
1
Hypopharyngeal Neoplasms
1
Head and Neck Neoplasms
1
Glioma
1
Glioblastoma
1
Extensive Stage Small Cell Lung Carcinoma
1
Carcinoma, Squamous Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma
1
Advanced Glioblastoma
1
Adenocarcinoma, Bronchiolo-Alveolar
1
Interventions
Nuclear Medicine Department, Hospital
6
Magnetic Resonance Spectroscopy
6
X-Rays
5
Specimen Handling
5
Phantoms, Imaging
5
Biopsy
5
Temozolomide
4
Irinotecan
3
ulixertinib
2
tipifarnib
2
selpercatinib
2
olaparib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
dinutuximab
2
Cyclophosphamide
2
trametinib
1
tazemetostat
1
talazoparib
1
saponin QA-21V1
1
palbociclib
1
lutetium Lu 177 dotatate
1
irinotecan sucrosofate
1
fludarabine phosphate
1
fludarabine
1
dabrafenib
1
Vincristine
1
Vemurafenib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neuroblastoma
×
Radiotherapy, Intensity-Modulated
×
30 days
×
Clear all
No trials found.